000 01459 a2200409 4500
005 20250515175354.0
264 0 _c20091022
008 200910s 0 0 eng d
022 _a1873-3492
024 7 _a10.1016/j.cca.2009.06.025
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aMa, Jing-Jing
245 0 0 _aEffects of NAT2 polymorphism on SASP pharmacokinetics in Chinese population.
_h[electronic resource]
260 _bClinica chimica acta; international journal of clinical chemistry
_cSep 2009
300 _a30-5 p.
_bdigital
500 _aPublication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAdministration, Oral
650 0 4 _aArylamine N-Acetyltransferase
_xgenetics
650 0 4 _aAsian People
_xgenetics
650 0 4 _aCalibration
650 0 4 _aChina
650 0 4 _aFeasibility Studies
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aPolymorphism, Genetic
650 0 4 _aQuality Control
650 0 4 _aSulfapyridine
_xanalogs & derivatives
650 0 4 _aSulfasalazine
_xadministration & dosage
650 0 4 _aYoung Adult
700 1 _aLiu, Cun-Gang
700 1 _aLi, Jin-Heng
700 1 _aCao, Xiao-Mei
700 1 _aSun, Sheng-Li
700 1 _aYao, Xuan
773 0 _tClinica chimica acta; international journal of clinical chemistry
_gvol. 407
_gno. 1-2
_gp. 30-5
856 4 0 _uhttps://doi.org/10.1016/j.cca.2009.06.025
_zAvailable from publisher's website
999 _c18977577
_d18977577